Gene · 3832
Papers3,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design principles for self-organization of mitotic spindle bipolarity. | Proc Natl Acad Sci U S A | 2025 | 40228138 | PubTator, text mining | PubMed |
| Targeting Eg5 using Arry520 combats gastric cancer by inducing monopolar spindles. | Gene | 2025 | 40187619 | PubTator, text mining | PubMed |
| uniDINO: Assay-independent feature extraction for fluorescence microscopy images. | Comput Struct Biotechnol J | 2025 | 40123801 | PubTator, text mining | PubMed |
| Identification of hub genes for the diagnosis and prognosis in triple negative breast cancer using transcriptome and differential methylation integration analysis. | J Cancer | 2025 | 40092695 | PubTator, text mining | PubMed |
| Mechanisms of Picrasma quassioides against hepatocellular carcinoma elucidated by network pharmacology and experimental validation. | Am J Transl Res | 2025 | 40092104 | PubTator, text mining | PubMed |
| Integrative analysis of serum proteomics and transcriptomics in hepatitis C. | Virol J | 2025 | 40082995 | PubTator, text mining | PubMed |
| KIF11 and KIF14 Are a Novel Potential Prognostic Biomarker in Patients with Endometrioid Carcinoma. | Cancers (Basel) | 2025 | 40075652 | PubTator, text mining | PubMed |
The Kinesin Eg5 Inhibitor K858 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma and Affects the Expression of Epithelial-mesenchymal Transition Related Markers: In vitro and In vivo Studies. | Anticancer Agents Med Chem | 2025 | 39995121 | PubTator, text mining | PubMed |
| IMERGE-FEP: Improving Relative Free Energy Calculation Convergence with Chemical Intermediates. | J Phys Chem B | 2025 | 39976528 | PubTator, text mining | PubMed |
| Integrative analysis of T cell-mediated tumor killing-related genes reveals KIF11 as a novel therapeutic target in esophageal squamous cell carcinoma. | J Transl Med | 2025 | 39966857 | PubTator, text mining | PubMed |
| Gene Variant Spectrum in Probands With Familial Exudative Vitreoretinopathy Using an Expanded Panel. | Invest Ophthalmol Vis Sci | 2025 | 39918476 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. | Curr Genomics | 2025 | 39911278 | PubTator, text mining | PubMed |
| Analysis and identification of potential biomarkers for dysfunctional uterine bleeding. | J Reprod Immunol | 2025 | 39862473 | PubTator, text mining | PubMed |
| Fragment-Based Drug Discovery of KIF11 Inhibitors for Glioblastoma Treatment: Molecular Insights and Therapeutic Potential. | Drug Res (Stuttg) | 2025 | 39842449 | PubTator, text mining | PubMed |
| 19S proteasome loss causes monopolar spindles through ubiquitin-independent KIF11 degradation. | bioRxiv | 2025 | 39829864 | PubTator, text mining | PubMed |
| Maternal ELL3 loss-of-function leads to oocyte aneuploidy and early miscarriage. | Nat Struct Mol Biol | 2025 | 39820605 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| High interstitial fluid pressure enhances USP1-dependent KIF11 protein stability to promote hepatocellular carcinoma progression. | J Transl Med | 2025 | 39810156 | PubTator, text mining | PubMed |
| Identification and validation of the important role of KIF11 in the development and progression of endometrial cancer. | J Transl Med | 2025 | 39806429 | PubTator, text mining | PubMed |
| Inferior sectoral chorioretinopathy in two patients with novel heterozygous KIF11 mutations. | Ophthalmic Genet | 2025 | 39803728 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3832/papers?page=9